Skip to Main Content
Immune System

Characterization of SSc-ILD patients and linkage to clinical outcomes

What is the purpose of this trial?

The purpose of this study is to better understand the development of scleroderma-related lung fibrosis (scarring)/ interstitial lung disease (ILD) and how certain molecular and cellular characteristics of scleroderma lung disease may be linked to clinical outcomes. Depending on your diagnosis date, study procedures may include screening form and questionnaires, physical examination, blood collection, high resolution computed tomography (hrCT), skin biopsy collection, and suture removal.

  • Trial with
    Boehringer Ingelheim Pharmaceuticals, Inc.
  • Ages
    18 years and older
  • Gender
    Both

Contact Information

For more information about this study, including how to volunteer, contact Stephanie Perez

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    06/28/2023
  • Study HIC
    #2000032581